• Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock International Opportunities Portfolio

+ Add to Watchlist

BRECX:US

27.47 USD 0.23 0.84%

As of 09:29:30 ET on 12/17/2014.

Snapshot for BlackRock International Opportunities Portfolio (BRECX)

Year To Date: -14.14% 3-Month: -8.32% 3-Year: +7.91% 52-Week Range: 27.18 - 33.43
1-Month: -4.95% 1-Year: -9.85% 5-Year: +2.74% Beta vs MXWDU: 1.03

Mutual Fund Chart for BRECX

No chart data available.
  • BRECX:US 27.24
  • 1M
  • 1Y
Interactive BRECX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BRECX

BlackRock International Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective seeks long-term capital appreciation. The Fund invests at least 80% of net assets in equity securities issued by international companies. The Fund may invest up to 40% of its net assets in stocks of issuers in emerging market countries.

Inception Date: 09-26-1997 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / IAN JAMIESON
Web Site: www.blackrock.com

Fundamentals for BRECX

NAV (on 2014-12-16) 27.24
Assets (M) (on 2014-12-16) 1,276.23
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for BRECX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-12) 0.52
Dividend Yield (ttm) 15.92

Fees & Expenses for BRECX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.98
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 2.23

Top Fund Holdings for BRECX

Filing Date: 10/31/2014
Name Position Value % of Total
Roche Holding AG 208,714 61,591,843 4.099%
Novartis AG 598,500 55,542,519 3.696%
Baidu Inc 175,150 41,820,566 2.783%
Imperial Tobacco Group PLC 912,300 39,631,825 2.638%
Anheuser-Busch InBev NV 339,779 37,679,545 2.508%
AstraZeneca PLC 502,600 36,713,957 2.443%
Teva Pharmaceutical Industries 531,000 29,985,570 1.996%
Actelion Ltd 229,855 27,374,632 1.822%
Liberty Global PLC 552,500 25,122,175 1.672%
Bayer AG 168,200 24,056,235 1.601%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil